NO2995308T3 - - Google Patents
Info
- Publication number
- NO2995308T3 NO2995308T3 NO14794605A NO14794605A NO2995308T3 NO 2995308 T3 NO2995308 T3 NO 2995308T3 NO 14794605 A NO14794605 A NO 14794605A NO 14794605 A NO14794605 A NO 14794605A NO 2995308 T3 NO2995308 T3 NO 2995308T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310162336.3A CN104138379B (zh) | 2013-05-06 | 2013-05-06 | 一种抗缺氧的药物组合物及其应用 |
| PCT/CN2014/075770 WO2014180238A1 (zh) | 2013-05-06 | 2014-04-21 | 一种抗缺氧的药物组合物及其应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2995308T3 true NO2995308T3 (no) | 2018-07-28 |
Family
ID=51847832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO14794605A NO2995308T3 (no) | 2013-05-06 | 2014-04-21 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9421181B2 (no) |
| EP (1) | EP2995308B1 (no) |
| CN (1) | CN104138379B (no) |
| ES (1) | ES2668525T3 (no) |
| NO (1) | NO2995308T3 (no) |
| WO (1) | WO2014180238A1 (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105497030A (zh) * | 2015-09-28 | 2016-04-20 | 汪道文 | 曲美他嗪在防治脓毒症心功能不全中的新作用 |
| CN106511437A (zh) * | 2016-12-27 | 2017-03-22 | 青海大学 | 一种红景天有效部位的制备及其医药用途 |
| CN110433263A (zh) * | 2019-09-25 | 2019-11-12 | 李明杰 | 一种防治多种脑动脉硬化中药组合物及其制备方法 |
| CN110898069A (zh) * | 2019-12-19 | 2020-03-24 | 青海大学 | 1,25-二羟基维生素d3在预防和治疗ams中的药物用途 |
| CN113491687A (zh) * | 2020-04-02 | 2021-10-12 | 常州高新技术产业开发区三维工业技术研究所有限公司 | 一种解毒药物组合物及其用途 |
| CN113491686A (zh) * | 2020-04-02 | 2021-10-12 | 常州高新技术产业开发区三维工业技术研究所有限公司 | 一种抗应激药物组合物及其用途 |
| CN112042796A (zh) * | 2020-08-03 | 2020-12-08 | 北京体育大学 | 一种抗缺氧能量棒及其制备方法和应用 |
| CN113499311B (zh) * | 2021-08-16 | 2022-05-20 | 沈阳药科大学 | 一种长春西汀鼻用纳米乳及其制备方法和用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6964969B2 (en) * | 2001-04-19 | 2005-11-15 | Mccleary Edward Larry | Composition and method for treating impaired or deteriorating neurological function |
| US6572899B1 (en) * | 2002-07-03 | 2003-06-03 | Vitacost.Com, Inc. | Memory loss treatment formulation |
| CN1723896A (zh) * | 2004-07-19 | 2006-01-25 | 胡才忠 | 长春西汀脂质体 |
| US20060211721A1 (en) * | 2005-03-21 | 2006-09-21 | Roberts Alan R | Nutraceutical formulation of a cognitive enhancement system |
| US8071610B2 (en) * | 2006-06-05 | 2011-12-06 | Josh Reynolds | Compositions and methods for enhancing brain function |
| US20070281961A1 (en) * | 2006-06-05 | 2007-12-06 | Brite Age | Modified Compositions And Methods For Enhancing Brain Function |
| CN101356972B (zh) * | 2007-07-30 | 2013-06-12 | 石药集团中奇制药技术（石家庄）有限公司 | 一种抗疲劳、耐缺氧的运动保健品 |
| US8349376B1 (en) * | 2011-03-08 | 2013-01-08 | Bezzek Mark S | Anti-dementia regimen |
-
2013
- 2013-05-06 CN CN201310162336.3A patent/CN104138379B/zh active Active
-
2014
- 2014-04-21 US US14/889,594 patent/US9421181B2/en active Active
- 2014-04-21 EP EP14794605.7A patent/EP2995308B1/en active Active
- 2014-04-21 ES ES14794605.7T patent/ES2668525T3/es active Active
- 2014-04-21 WO PCT/CN2014/075770 patent/WO2014180238A1/zh active Application Filing
- 2014-04-21 NO NO14794605A patent/NO2995308T3/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014180238A1 (zh) | 2014-11-13 |
| US20160081966A1 (en) | 2016-03-24 |
| EP2995308A1 (en) | 2016-03-16 |
| US9421181B2 (en) | 2016-08-23 |
| EP2995308B1 (en) | 2018-02-28 |
| CN104138379B (zh) | 2020-07-03 |
| CN104138379A (zh) | 2014-11-12 |
| EP2995308A4 (en) | 2016-12-07 |
| ES2668525T3 (es) | 2018-05-18 |